Overview
Oculocerebrorenal syndrome of Lowe, also known as Lowe syndrome or OCRL (oculocerebrorenal) syndrome, is a rare X-linked multisystem disorder that primarily affects the eyes, brain, and kidneys. It is caused by mutations in the OCRL gene located on the X chromosome, which encodes the enzyme phosphatidylinositol 4,5-bisphosphate 5-phosphatase. Because of its X-linked inheritance, the condition almost exclusively affects males, while females are typically carriers who may show mild features such as lens opacities. The hallmark features of Lowe syndrome include congenital bilateral cataracts (present at birth), intellectual disability of varying severity, and renal tubular dysfunction (renal Fanconi syndrome). The congenital cataracts often lead to glaucoma, and many affected individuals develop significant visual impairment. Neurological manifestations include hypotonia (reduced muscle tone) from birth, intellectual disability ranging from mild to severe, behavioral difficulties, and seizures in some patients. The renal Fanconi syndrome leads to loss of important substances in the urine, including bicarbonate, amino acids, phosphate, and low-molecular-weight proteins, which can progress to chronic kidney disease over time. Additional features may include short stature, joint hypermobility, vitamin D-resistant rickets due to phosphate wasting, and a tendency to develop renal cysts. There is currently no cure for Lowe syndrome, and treatment is supportive and symptomatic. Management typically involves early cataract surgery, treatment of glaucoma, physical and occupational therapy for hypotonia and developmental delays, and medical management of renal tubular acidosis with bicarbonate supplementation, phosphate replacement, and vitamin D supplementation to prevent or treat rickets. Seizures are managed with standard anticonvulsant medications. Regular monitoring of kidney function is essential, as progressive renal insufficiency may develop, particularly in adolescence and adulthood. A multidisciplinary approach involving ophthalmology, nephrology, neurology, and developmental specialists is recommended for optimal care.
Also known as:
Clinical phenotype terms— hover any for plain English:
X-linked recessive
Carried on the X chromosome; typically affects males more than females
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for Oculocerebrorenal syndrome of Lowe.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Oculocerebrorenal syndrome of Lowe at this time.
New trials open frequently. Follow this disease to get notified.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Oculocerebrorenal syndrome of Lowe.
Community
No community posts yet. Be the first to share your experience with Oculocerebrorenal syndrome of Lowe.
Start the conversation →Latest news about Oculocerebrorenal syndrome of Lowe
No recent news articles for Oculocerebrorenal syndrome of Lowe.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Oculocerebrorenal syndrome of Lowe
What is Oculocerebrorenal syndrome of Lowe?
Oculocerebrorenal syndrome of Lowe, also known as Lowe syndrome or OCRL (oculocerebrorenal) syndrome, is a rare X-linked multisystem disorder that primarily affects the eyes, brain, and kidneys. It is caused by mutations in the OCRL gene located on the X chromosome, which encodes the enzyme phosphatidylinositol 4,5-bisphosphate 5-phosphatase. Because of its X-linked inheritance, the condition almost exclusively affects males, while females are typically carriers who may show mild features such as lens opacities. The hallmark features of Lowe syndrome include congenital bilateral cataracts (pr
How is Oculocerebrorenal syndrome of Lowe inherited?
Oculocerebrorenal syndrome of Lowe follows a x-linked recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Oculocerebrorenal syndrome of Lowe typically begin?
Typical onset of Oculocerebrorenal syndrome of Lowe is neonatal. Age of onset can vary across affected individuals.
Which specialists treat Oculocerebrorenal syndrome of Lowe?
2 specialists and care centers treating Oculocerebrorenal syndrome of Lowe are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.